Valeant Pharmaceuticals International is reportedly close to reaching a deal to acquire Salix Pharmaceuticals Ltd. (NASDAQ:SLXP). On Monday shares of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) closed at $155.76. Company’s sales growth for last 5 years was 39.20% and EPS growth for next 5 years is recorded as 19.32%.
On February 19, it was reported that, Pattern Energy Group LP (“Pattern Development”) announced it has signed a joint venture (JV) agreement with CEMEX Energia, a subsidiary of CEMEX, S.A.B. de C.V. (NYSE:CX) The CEMEX Energia/Pattern Development JV envisions advancing development opportunities and acquiring projects from third parties in the early to mid-stages of their development process.CEMEX, S.A.B. de C.V. (NYSE:CX) in last trading activity increased 1.00% to close at $10.06. Company weekly performance is 2.24% while its quarterly performance stands at -19.13%. CEMEX, S.A.B. de C.V. (NYSE:CX) is -27.21% away from its 52 week high.
Yingli Green Energy Australia, known as Yingli Solar, a wholly-owned subsidiary of Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) has installed a 100kWp solar photovoltaic (PV) system at Fisher’s Group through its installation partner Gippsland Solar. On Monday shares of Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) closed at $2.12. Company’s sales growth for last 5 years was 12.20%.
Libbey Inc. (NYSEMKT:LBY) cash dividend payment of $0.11 per share is scheduled to be paid on March 03, 2015. Shareholders who purchased LBY stock prior to the ex-dividend date are eligible for the cash dividend payment. Libbey Inc. (NYSEMKT:LBY) has 1.30% insider ownership while its institutional ownership stands at 85.30%. In last trading activity company’s stock closed at $36.68.
Atossa Genetics Inc. (Nasdaq:ATOS) announced that it will exhibit upcoming medical conference: The National Consortium of Breast Centers Meeting to be held March 14-18, 2015 in Las Vegas, Nevada. This conference will include the FullCYTE Breast Aspirator device, which is used to collect nipple aspirate fluid for cytological analysis at a laboratory. On last trading day Atossa Genetics, Inc. (NASDAQ:ATOS) increased 3.05% to close at $1.69. Its volatility for the week is 12.34% while volatility for the month is 11.19%. Atossa Genetics, Inc. (NASDAQ:ATOS) monthly performance is 37.40%.